Chestnut Hill, MA, United States of America

Daniel L Silverio

This inventor holds 1 USPTO granted patent. Top assignee: The Trustees of Boston College. Active years: 2016.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel L. Silverio

Introduction

Daniel L. Silverio is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of organic chemistry, particularly in the synthesis of chiral products. His work focuses on developing practical and efficient methods for the synthesis of amines and alcohols, which are essential for creating biologically active molecules.

Latest Patents

Daniel L. Silverio holds a patent for "Simple organic molecules as catalysts for practical and efficient enantioselective synthesis of amines and alcohols." This invention provides organic molecules and methods for reactions between organoboron reagents and double bonds, such as imines or carbonyls. The goal is to stereoselectively produce chiral products, including amines and alcohols, which are valuable in the preparation of biologically active compounds. He has 1 patent to his name.

Career Highlights

Daniel is affiliated with The Trustees of Boston College, where he contributes to research and innovation in chemistry. His work has garnered attention for its practical applications in the synthesis of important chemical entities.

Collaborations

Throughout his career, Daniel has collaborated with esteemed colleagues, including Amir H. Hoveyda and Tatiana Pilyugina. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Daniel L. Silverio's contributions to organic chemistry and his innovative patent demonstrate his commitment to advancing the field. His work not only showcases his expertise but also highlights the importance of collaboration in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…